Cost of Harvoni
We all know that the cost of Harvoni is really out of reach for most of us. In the US its $94,000. To our Southern neighbor, Harvoni cost in Mexico is around $82,000. And to our North, cost of Harvoni in Canada is $92,000. Pretty much anywhere in the Western or the developed world, the prices for Harvoni are astronomical. Harvoni is manufactured by Gilead Sciences in the US. In India, its manufactured by several Indian pharmaceutical companies, that were granted the patent and license by Gilead. Harvoni main active pharmaceutical ingredients (API) are ledipasvir 90mg and sofosbuvir 400mg.
There is a rumor that cost of Harvoni maybe reduced. In reality it doesn’t matter unless you will pay the co-pay of $18,000 to $35,000 to get Harvoni. It would be much safer (reduce wait time) and financially intelligent to get the licensed generic from India. We helped 1000s of patients get cured and live a happy life without hepatitis C. Gilead gave the patent to have India manufacture it for a fraction of the price, around $1000.
If you are looking to get Harvoni and do not want to wait for your liver to get worse (higher fibroscan) get started today.
Why is Harvoni so expensive?
Harvoni is priced ridiculously high because state healthcare systems MUST pay for this life saving medicine. You have to think about it this way; the law stipulates that anyone with hepatitis C that is under state healthcare like Medicaid or Medicare must be treated if a treatment is available. So, when Harvoni was made available as its predecessor Sovaldi, hep c patients had to be treated, regardless of price.
So, how many patients could be treated with Harvoni in a specific state? Well, as you very well heard that many healthcare budgets around the country almost went bust due to pricey Harvoni and Sovaldi. Approximately $1 billion was spent to cure 700,000 patients on Medicare. Less than 3% of the country’s hepatitis C population was treated. Senator Chuck Grassley on the 2014 Sovaldi report on this matter deserves a once over.
Gilead Sciences used this method to increase substantial profits in the years 2013 to 2017. It will continue, unless they face stiff competition from AbbVie’s Mavyret.
Even though for you and I the price of Harvoni in India is a lot less, but for Indians living on less than a dollar a day, a $1000 is equivalent to $150,000 to cure their hep C.
As HCV advocates, we feel extremely fortunate to have access to Harvoni at a very low price. Your support helps us make an impact on one American child suffering with hepatitis C.